title: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.
abstract: MicroRNAs (miRNAs) are small non-coding RNAs of 19-25 nucleotides that are involved in the regulation of critical cell processes such as apoptosis, cell proliferation and differentiation. However, little is known about the role of miRNAs in granulopoiesis. Here, we report the expression of miRNAs in acute promyelocytic leukemia patients and cell lines during all-trans-retinoic acid (ATRA) treatment by using a miRNA microarrays platform and quantitative real time-polymerase chain reaction (qRT-PCR). We found upregulation of miR-15a, miR-15b, miR-16-1, let-7a-3, let-7c, let-7d, miR-223, miR-342 and miR-107, whereas miR-181b was downregulated. Among the upregulated miRNAs, miR-107 is predicted to target NFI-A, a gene that has been involved in a regulatory loop involving miR-223 and C/EBPa during granulocytic differentiation. Indeed, we have confirmed that miR-107 targets NF1-A. To get insights about ATRA regulation of miRNAs, we searched for ATRA-modulated transcription factors binding sites in the upstream genomic region of the let-7a-3/let-7b cluster and identified several putative nuclear factor-kappa B (NF-kappaB) consensus elements. The use of reporter gene assays, chromatin immunoprecipitation and site-directed mutagenesis revealed that one proximal NF-kappaB binding site is essential for the transactivation of the let-7a-3/let-7b cluster. Finally, we show that ATRA downregulation of RAS and Bcl2 correlate with the activation of known miRNA regulators of those proteins, let-7a and miR-15a/miR-16-1, respectively.
authors.affiliation: Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.
authors.forename: R
authors.initials: R
authors.lastname: Garzon
authors.forename: F
authors.initials: F
authors.lastname: Pichiorri
authors.forename: T
authors.initials: T
authors.lastname: Palumbo
authors.forename: M
authors.initials: M
authors.lastname: Visentini
authors.forename: R
authors.initials: R
authors.lastname: Aqeilan
authors.forename: A
authors.initials: A
authors.lastname: Cimmino
authors.forename: H
authors.initials: H
authors.lastname: Wang
authors.forename: H
authors.initials: H
authors.lastname: Sun
authors.forename: S
authors.initials: S
authors.lastname: Volinia
authors.forename: H
authors.initials: H
authors.lastname: Alder
authors.forename: G A
authors.initials: GA
authors.lastname: Calin
authors.forename: C-G
authors.initials: CG
authors.lastname: Liu
authors.forename: M
authors.initials: M
authors.lastname: Andreeff
authors.forename: C M
authors.initials: CM
authors.lastname: Croce
mesh_terms: D001483:Base Sequence; D015152:Blotting, Northern; D015153:Blotting, Western; D002454:Cell Differentiation / Q000187:drug effects*; D017931:DNA Primers; D015870:Gene Expression / Q000187:drug effects*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000473:pathology*; D008156:Luciferases / Q000235:genetics; D035683:MicroRNAs / Q000235:genetics*; D034741:RNA, Small Interfering; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014212:Tretinoin / Q000494:pharmacology*
chemical_list: D017931:DNA Primers; D035683:MicroRNAs; D034741:RNA, Small Interfering; D014212:Tretinoin; D008156:Luciferases